Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
84 participants
OBSERVATIONAL
2023-10-25
2024-06-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
control group
Infertile women who will be included in the control group will be interviewed twice in total. Pretest data will be obtained by applying the "Personal Information Form", "Infertility Impact Scale", "Infertility Self-Efficacy Scale - Short Form" and "Coping with Infertility Stress Scale" in the first interview. Four weeks after obtaining the pre-test data, post-test data will be obtained by applying the "Infertility Impact Scale", "Infertility Self-Efficacy Scale - Short Form" and "Coping with Infertility Stress Scale".
No interventions assigned to this group
intervention group
Before starting motivational interviews with infertile women in the intervention group, pre-test data will be obtained by applying the "Personal Information Form", "Infertility Impact Scale", "Infertility Self-Efficacy Scale - Short Form" and "Coping with Infertility Stress Scale". A total of 4 sessions of motivational interviews will be held for infertile women, 1 session per week for four weeks. At the end of four weeks, post-test data will be obtained by applying the "Infertility Impact Scale", "Infertility Self-Efficacy Scale - Short Form" and "Coping with Infertility Stress Scale".
Motivational Interview
The data of the research will be collected between October 2023 and June 2024. Each meeting will last approximately 15-30 minutes.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Motivational Interview
The data of the research will be collected between October 2023 and June 2024. Each meeting will last approximately 15-30 minutes.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kahramanmaras Sutcu Imam University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eda Sever
student
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Esra Karataş Okyay
Role: PRINCIPAL_INVESTIGATOR
Kahramanmaras Sutcu Imam University
Eda Sever
Role: STUDY_DIRECTOR
Kahramanmaras Sutcu Imam University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Eda Sever
Kahramanmaraş, Onikişubat, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KSIU-SBF-ES-01
Identifier Type: -
Identifier Source: org_study_id